Led the research effort in an emerging heart failure therapy area. Acted as the primary technical lead, responsible for research strategy and execution, clinical study design, and intellectual property development. Part of a core team that brought an implantable neural stimulation system through pilot pre-clinical studies, clinical studies, regulatory approval, and commercialization.Formerly Cyberonics. Cyberonics merged with Sorin Group in 2015 to form LivaNova.

Part of a 7-person team that founded and built a venture-backed medical device start-up company that successfully brought several remote patient monitoring products from concept to market. Led the company's research and technology efforts, including pre-clinical and clinical design and execution, arrhythmia algorithm design, and intellectual property development. Corventis was acquired by Medtronic for $130 million in 2014 .

Led the research effort in an emerging heart failure therapy area, including pre-clinical and clinical study design and execution, data analysis and interpretation, and intellectual property development. Formerly Guidant Cardiac Rhythm Management. Guidant was acquired by Boston Scientific in 2006.